Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
Provided By GlobeNewswire
Last update: Aug 1, 2024
Topline data from completed Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease targeted for September 2024
Read more at globenewswire.com
